nodes	percent_of_prediction	percent_of_DWPC	metapath
Apixaban—ABCG2—Riluzole—amyotrophic lateral sclerosis	0.589	0.708	CbGbCtD
Apixaban—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.243	0.292	CbGbCtD
Apixaban—Subdural haematoma—Riluzole—amyotrophic lateral sclerosis	0.0193	0.124	CcSEcCtD
Apixaban—Subarachnoid haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.0185	0.119	CcSEcCtD
Apixaban—Cerebral haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00729	0.0469	CcSEcCtD
Apixaban—Gingival bleeding—Riluzole—amyotrophic lateral sclerosis	0.00711	0.0458	CcSEcCtD
Apixaban—Haematemesis—Riluzole—amyotrophic lateral sclerosis	0.00581	0.0374	CcSEcCtD
Apixaban—Metrorrhagia—Riluzole—amyotrophic lateral sclerosis	0.00565	0.0364	CcSEcCtD
Apixaban—Haemoptysis—Riluzole—amyotrophic lateral sclerosis	0.00545	0.0351	CcSEcCtD
Apixaban—Petechiae—Riluzole—amyotrophic lateral sclerosis	0.00491	0.0316	CcSEcCtD
Apixaban—Gamma-glutamyltransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00491	0.0316	CcSEcCtD
Apixaban—Blood bilirubin increased—Riluzole—amyotrophic lateral sclerosis	0.00427	0.0275	CcSEcCtD
Apixaban—Melaena—Riluzole—amyotrophic lateral sclerosis	0.00394	0.0254	CcSEcCtD
Apixaban—Ecchymosis—Riluzole—amyotrophic lateral sclerosis	0.00365	0.0235	CcSEcCtD
Apixaban—Diabetes mellitus—Riluzole—amyotrophic lateral sclerosis	0.00337	0.0217	CcSEcCtD
Apixaban—Blood alkaline phosphatase increased—Riluzole—amyotrophic lateral sclerosis	0.00337	0.0217	CcSEcCtD
Apixaban—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00293	0.0189	CcSEcCtD
Apixaban—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.00271	0.0174	CcSEcCtD
Apixaban—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.00265	0.017	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00264	0.017	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00258	0.0166	CcSEcCtD
Apixaban—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00215	0.0139	CcSEcCtD
Apixaban—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00214	0.0137	CcSEcCtD
Apixaban—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00213	0.0137	CcSEcCtD
Apixaban—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.00204	0.0131	CcSEcCtD
Apixaban—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00203	0.013	CcSEcCtD
Apixaban—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.002	0.0129	CcSEcCtD
Apixaban—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00199	0.0128	CcSEcCtD
Apixaban—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00199	0.0128	CcSEcCtD
Apixaban—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00189	0.0122	CcSEcCtD
Apixaban—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00184	0.0118	CcSEcCtD
Apixaban—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00183	0.0118	CcSEcCtD
Apixaban—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00183	0.0118	CcSEcCtD
Apixaban—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00163	0.0105	CcSEcCtD
Apixaban—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00158	0.0102	CcSEcCtD
Apixaban—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00155	0.00998	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00149	0.0096	CcSEcCtD
Apixaban—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00144	0.00927	CcSEcCtD
Apixaban—Shock—Riluzole—amyotrophic lateral sclerosis	0.00142	0.00912	CcSEcCtD
Apixaban—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00141	0.00909	CcSEcCtD
Apixaban—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00141	0.00907	CcSEcCtD
Apixaban—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.0014	0.009	CcSEcCtD
Apixaban—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00135	0.00866	CcSEcCtD
Apixaban—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00124	0.008	CcSEcCtD
Apixaban—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00106	0.00683	CcSEcCtD
Apixaban—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000952	0.00613	CcSEcCtD
Apixaban—Rash—Riluzole—amyotrophic lateral sclerosis	0.000908	0.00584	CcSEcCtD
Apixaban—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000907	0.00584	CcSEcCtD
Apixaban—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000856	0.0055	CcSEcCtD
Apixaban—F10—Complement and Coagulation Cascades—C3—amyotrophic lateral sclerosis	0.000203	0.016	CbGpPWpGaD
Apixaban—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000196	0.0154	CbGpPWpGaD
Apixaban—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000183	0.0144	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.00018	0.0142	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000164	0.013	CbGpPWpGaD
Apixaban—F10—Metabolism of proteins—PIGW—amyotrophic lateral sclerosis	0.000158	0.0124	CbGpPWpGaD
Apixaban—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000156	0.0123	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000153	0.012	CbGpPWpGaD
Apixaban—F10—Hemostasis—KIFAP3—amyotrophic lateral sclerosis	0.000152	0.012	CbGpPWpGaD
Apixaban—CYP2J2—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000145	0.0115	CbGpPWpGaD
Apixaban—F10—Metabolism of proteins—XRN2—amyotrophic lateral sclerosis	0.000144	0.0114	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000144	0.0113	CbGpPWpGaD
Apixaban—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000121	0.0095	CbGpPWpGaD
Apixaban—F10—Metabolism of proteins—YIF1A—amyotrophic lateral sclerosis	0.00012	0.00942	CbGpPWpGaD
Apixaban—F10—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	0.000105	0.0083	CbGpPWpGaD
Apixaban—CYP2J2—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000104	0.00823	CbGpPWpGaD
Apixaban—CYP2J2—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000103	0.00812	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	9.85e-05	0.00776	CbGpPWpGaD
Apixaban—F10—Metabolism of proteins—EXOSC9—amyotrophic lateral sclerosis	9.85e-05	0.00776	CbGpPWpGaD
Apixaban—F10—Hemostasis—RAB5A—amyotrophic lateral sclerosis	9.79e-05	0.00772	CbGpPWpGaD
Apixaban—F10—Hemostasis—PFN1—amyotrophic lateral sclerosis	9.48e-05	0.00747	CbGpPWpGaD
Apixaban—F10—Metabolism of proteins—TUBA4A—amyotrophic lateral sclerosis	8.29e-05	0.00653	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—TPK1—amyotrophic lateral sclerosis	8e-05	0.00631	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—VAPB—amyotrophic lateral sclerosis	8e-05	0.00631	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	7.46e-05	0.00588	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—VAPA—amyotrophic lateral sclerosis	7.32e-05	0.00577	CbGpPWpGaD
Apixaban—CYP2C19—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	7.31e-05	0.00576	CbGpPWpGaD
Apixaban—F10—Metabolism of proteins—DCTN1—amyotrophic lateral sclerosis	7.05e-05	0.00555	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.81e-05	0.00536	CbGpPWpGaD
Apixaban—CYP3A5—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	6.73e-05	0.0053	CbGpPWpGaD
Apixaban—CYP2C8—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.44e-05	0.00507	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—FIG4—amyotrophic lateral sclerosis	6.4e-05	0.00504	CbGpPWpGaD
Apixaban—ABCG2—HIF-2-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	6.27e-05	0.00494	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	6.03e-05	0.00475	CbGpPWpGaD
Apixaban—CYP2C8—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	5.83e-05	0.00459	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—DAO—amyotrophic lateral sclerosis	5.79e-05	0.00456	CbGpPWpGaD
Apixaban—CYP2C19—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.75e-05	0.00453	CbGpPWpGaD
Apixaban—CYP1A2—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	5.7e-05	0.00449	CbGpPWpGaD
Apixaban—CYP2C9—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.24e-05	0.00413	CbGpPWpGaD
Apixaban—ABCG2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	5.21e-05	0.0041	CbGpPWpGaD
Apixaban—F10—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	5.2e-05	0.0041	CbGpPWpGaD
Apixaban—CYP2C19—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	5.2e-05	0.0041	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	4.92e-05	0.00387	CbGpPWpGaD
Apixaban—ABCG2—Fluoropyrimidine Activity—TP53—amyotrophic lateral sclerosis	4.85e-05	0.00382	CbGpPWpGaD
Apixaban—ABCB1—Allograft Rejection—CASP9—amyotrophic lateral sclerosis	4.83e-05	0.00381	CbGpPWpGaD
Apixaban—CYP2C9—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	4.74e-05	0.00374	CbGpPWpGaD
Apixaban—F10—Hemostasis—SOD1—amyotrophic lateral sclerosis	4.59e-05	0.00361	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	4.49e-05	0.00354	CbGpPWpGaD
Apixaban—CYP1A2—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.48e-05	0.00353	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—PLB1—amyotrophic lateral sclerosis	4.39e-05	0.00346	CbGpPWpGaD
Apixaban—F10—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	4.11e-05	0.00324	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	4.1e-05	0.00323	CbGpPWpGaD
Apixaban—CYP1A2—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	4.05e-05	0.00319	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—GSR—amyotrophic lateral sclerosis	4.05e-05	0.00319	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	4e-05	0.00316	CbGpPWpGaD
Apixaban—ABCB1—Allograft Rejection—CD40LG—amyotrophic lateral sclerosis	3.89e-05	0.00307	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	3.81e-05	0.00301	CbGpPWpGaD
Apixaban—ABCG2—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	3.69e-05	0.00291	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	3.69e-05	0.0029	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	3.66e-05	0.00289	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	3.65e-05	0.00288	CbGpPWpGaD
Apixaban—CYP2C8—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	3.63e-05	0.00286	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	3.59e-05	0.00283	CbGpPWpGaD
Apixaban—ABCB1—Allograft Rejection—C3—amyotrophic lateral sclerosis	3.44e-05	0.00271	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	3.41e-05	0.00268	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	3.38e-05	0.00266	CbGpPWpGaD
Apixaban—ABCG2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	3.36e-05	0.00265	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	3.34e-05	0.00263	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—CHAT—amyotrophic lateral sclerosis	3.32e-05	0.00262	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	3.28e-05	0.00259	CbGpPWpGaD
Apixaban—CYP2C19—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	3.24e-05	0.00255	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—VAPB—amyotrophic lateral sclerosis	3.22e-05	0.00254	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—TPK1—amyotrophic lateral sclerosis	3.22e-05	0.00254	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	3.2e-05	0.00252	CbGpPWpGaD
Apixaban—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	3.13e-05	0.00246	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	3.12e-05	0.00246	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	3.1e-05	0.00245	CbGpPWpGaD
Apixaban—CYP1A2—Phase II conjugation—GSTP1—amyotrophic lateral sclerosis	3.1e-05	0.00244	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	3.09e-05	0.00243	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.03e-05	0.00239	CbGpPWpGaD
Apixaban—CYP3A5—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.01e-05	0.00237	CbGpPWpGaD
Apixaban—CYP3A5—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.97e-05	0.00234	CbGpPWpGaD
Apixaban—CYP2C9—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	2.95e-05	0.00233	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—VAPA—amyotrophic lateral sclerosis	2.94e-05	0.00232	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	2.92e-05	0.0023	CbGpPWpGaD
Apixaban—ABCG2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	2.85e-05	0.00225	CbGpPWpGaD
Apixaban—ABCG2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	2.85e-05	0.00225	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	2.85e-05	0.00225	CbGpPWpGaD
Apixaban—ABCB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	2.82e-05	0.00222	CbGpPWpGaD
Apixaban—F10—Hemostasis—IGF1—amyotrophic lateral sclerosis	2.8e-05	0.0022	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.74e-05	0.00216	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	2.7e-05	0.00213	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	2.65e-05	0.00209	CbGpPWpGaD
Apixaban—CYP2C8—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.61e-05	0.00205	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—FIG4—amyotrophic lateral sclerosis	2.57e-05	0.00203	CbGpPWpGaD
Apixaban—CYP2C8—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.57e-05	0.00203	CbGpPWpGaD
Apixaban—ABCG2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	2.54e-05	0.002	CbGpPWpGaD
Apixaban—CYP1A2—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	2.52e-05	0.00199	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	2.49e-05	0.00197	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	2.46e-05	0.00194	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	2.39e-05	0.00188	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—DAO—amyotrophic lateral sclerosis	2.33e-05	0.00183	CbGpPWpGaD
Apixaban—CYP2C19—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.33e-05	0.00183	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—VAPB—amyotrophic lateral sclerosis	2.31e-05	0.00182	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—TPK1—amyotrophic lateral sclerosis	2.31e-05	0.00182	CbGpPWpGaD
Apixaban—CYP2C19—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.3e-05	0.00181	CbGpPWpGaD
Apixaban—F10—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	2.2e-05	0.00173	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	2.19e-05	0.00173	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	2.13e-05	0.00167	CbGpPWpGaD
Apixaban—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.12e-05	0.00167	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—VAPA—amyotrophic lateral sclerosis	2.11e-05	0.00166	CbGpPWpGaD
Apixaban—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.09e-05	0.00165	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.08e-05	0.00164	CbGpPWpGaD
Apixaban—ABCB1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	2.04e-05	0.0016	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	2.01e-05	0.00158	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	2e-05	0.00158	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—TPK1—amyotrophic lateral sclerosis	2e-05	0.00157	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—VAPB—amyotrophic lateral sclerosis	2e-05	0.00157	CbGpPWpGaD
Apixaban—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	1.99e-05	0.00157	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.96e-05	0.00155	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	1.92e-05	0.00151	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.86e-05	0.00147	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—FIG4—amyotrophic lateral sclerosis	1.84e-05	0.00145	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—VAPA—amyotrophic lateral sclerosis	1.83e-05	0.00144	CbGpPWpGaD
Apixaban—F10—Hemostasis—VEGFA—amyotrophic lateral sclerosis	1.83e-05	0.00144	CbGpPWpGaD
Apixaban—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	1.82e-05	0.00143	CbGpPWpGaD
Apixaban—CYP1A2—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	1.81e-05	0.00143	CbGpPWpGaD
Apixaban—CYP1A2—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	1.79e-05	0.00141	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.79e-05	0.00141	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—TPK1—amyotrophic lateral sclerosis	1.78e-05	0.00141	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—VAPB—amyotrophic lateral sclerosis	1.78e-05	0.00141	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PLB1—amyotrophic lateral sclerosis	1.76e-05	0.00139	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	1.74e-05	0.00137	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	1.74e-05	0.00137	CbGpPWpGaD
Apixaban—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	1.73e-05	0.00136	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	1.71e-05	0.00135	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.7e-05	0.00134	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—DAO—amyotrophic lateral sclerosis	1.67e-05	0.00131	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.66e-05	0.00131	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.64e-05	0.00129	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	1.63e-05	0.00129	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—GSR—amyotrophic lateral sclerosis	1.63e-05	0.00128	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	1.63e-05	0.00128	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	1.63e-05	0.00128	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—FIG4—amyotrophic lateral sclerosis	1.6e-05	0.00126	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	1.59e-05	0.00125	CbGpPWpGaD
Apixaban—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	1.54e-05	0.00122	CbGpPWpGaD
Apixaban—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	1.54e-05	0.00122	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.52e-05	0.00119	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.52e-05	0.00119	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	1.49e-05	0.00117	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.48e-05	0.00117	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—DAO—amyotrophic lateral sclerosis	1.44e-05	0.00114	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	1.43e-05	0.00112	CbGpPWpGaD
Apixaban—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	1.4e-05	0.0011	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	1.39e-05	0.0011	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	1.39e-05	0.00109	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	1.39e-05	0.00109	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.38e-05	0.00109	CbGpPWpGaD
Apixaban—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	1.38e-05	0.00109	CbGpPWpGaD
Apixaban—F10—Hemostasis—TP53—amyotrophic lateral sclerosis	1.38e-05	0.00109	CbGpPWpGaD
Apixaban—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	1.38e-05	0.00108	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—APOE—amyotrophic lateral sclerosis	1.35e-05	0.00106	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—CHAT—amyotrophic lateral sclerosis	1.34e-05	0.00105	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	1.31e-05	0.00103	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	1.3e-05	0.00102	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.3e-05	0.00102	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	1.29e-05	0.00102	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	1.27e-05	0.001	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PLB1—amyotrophic lateral sclerosis	1.26e-05	0.000996	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	1.26e-05	0.000992	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.18e-05	0.000931	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	1.18e-05	0.000926	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—GSR—amyotrophic lateral sclerosis	1.17e-05	0.000919	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	1.11e-05	0.000875	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PLB1—amyotrophic lateral sclerosis	1.09e-05	0.000863	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	1.08e-05	0.000853	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	1.07e-05	0.000845	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	1.07e-05	0.000845	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—GSR—amyotrophic lateral sclerosis	1.01e-05	0.000796	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—DAO—amyotrophic lateral sclerosis	1e-05	0.000792	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	1e-05	0.000792	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	9.81e-06	0.000773	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	9.77e-06	0.00077	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—CHAT—amyotrophic lateral sclerosis	9.58e-06	0.000755	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	9.54e-06	0.000752	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.25e-06	0.000729	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	9.2e-06	0.000725	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	9.12e-06	0.000719	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	9.02e-06	0.000711	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	8.91e-06	0.000702	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	8.8e-06	0.000694	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	8.57e-06	0.000676	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	8.53e-06	0.000672	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	8.3e-06	0.000654	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	8.22e-06	0.000648	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	8.21e-06	0.000647	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	7.75e-06	0.000611	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	7.61e-06	0.0006	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	7.57e-06	0.000597	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	7.49e-06	0.00059	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	7.41e-06	0.000584	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	7.23e-06	0.00057	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.19e-06	0.000566	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	7.03e-06	0.000554	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	6.76e-06	0.000532	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	6.75e-06	0.000532	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.6e-06	0.00052	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	6.44e-06	0.000508	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	6.4e-06	0.000504	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	6.16e-06	0.000485	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	5.88e-06	0.000463	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	5.77e-06	0.000455	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—APOE—amyotrophic lateral sclerosis	5.43e-06	0.000428	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	5.42e-06	0.000427	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	5.27e-06	0.000415	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	5.19e-06	0.000409	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.15e-06	0.000406	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.73e-06	0.000373	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	4.63e-06	0.000365	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.46e-06	0.000351	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	4.45e-06	0.000351	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	4.22e-06	0.000333	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.1e-06	0.000323	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.98e-06	0.000314	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—APOE—amyotrophic lateral sclerosis	3.89e-06	0.000307	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.89e-06	0.000306	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.72e-06	0.000293	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.66e-06	0.000288	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.63e-06	0.000286	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	3.61e-06	0.000284	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.57e-06	0.000281	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	3.37e-06	0.000266	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.34e-06	0.000263	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.1e-06	0.000244	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	3.01e-06	0.000237	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	2.94e-06	0.000231	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.85e-06	0.000225	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	2.74e-06	0.000216	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.67e-06	0.00021	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.39e-06	0.000189	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	2.34e-06	0.000185	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.31e-06	0.000182	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.2e-06	0.000173	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.06e-06	0.000162	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.01e-06	0.000159	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.88e-06	0.000148	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	1.81e-06	0.000143	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.61e-06	0.000127	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.24e-06	9.77e-05	CbGpPWpGaD
